These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37005324)

  • 1. Renal Artery Stenosis Complicated with Primary Aldosteronism.
    Bao M; Li J
    Int Heart J; 2023; 64(2):321-325. PubMed ID: 37005324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hydronephrosis complicated with primary aldosteronism: a case report and review of the literature.
    Sun J; Zeng Q; Lai L; Gu M; Liu D; Wu G; Peng C; Yang S; Li Q; Lu J
    J Med Case Rep; 2024 Oct; 18(1):463. PubMed ID: 39369228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone-producing adenoma associated with non-suppressed renin: a case series.
    Jansen PM; Stowasser M
    J Hum Hypertens; 2022 Apr; 36(4):373-380. PubMed ID: 33785905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case series: Primary aldosteronism diagnosed despite normal screening investigations: A report of three cases.
    Jia M; Lin L; Yu H; Yang B; Xu X; Song X
    Medicine (Baltimore); 2023 May; 102(20):e33724. PubMed ID: 37335717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
    Beger C; Karg T; Hinrichs JB; Ringe B; Haller H; Meyer BC; Limbourg FP
    Blood Press; 2023 Dec; 32(1):2179340. PubMed ID: 36803263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of primary aldosteronism with a negative aldosterone-to-renin ratio.
    Liu F; Wang L; Ding Y
    BMC Cardiovasc Disord; 2021 Jul; 21(1):350. PubMed ID: 34294029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 58-year-old hypertensive patient with primary hyperaldosteronism and renal artery stenosis].
    Nguyen Quang M; Krüger B; Krüger CD; Walberer A; Schenck B; Kisters K; Wenning M; Krämer BK
    Med Klin (Munich); 2010 Apr; 105(4):276-80. PubMed ID: 20455049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperaldosteronism].
    Scholl UI
    Internist (Berl); 2021 Mar; 62(3):245-251. PubMed ID: 33599784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of concurrent primary aldosteronism and renal artery stenosis: A retrospective case-control study.
    Meng X; Yang YK; Li YH; Fan P; Zhang Y; Yang KQ; Wu HY; Jiang XJ; Cai J; Zhou XL
    Clin Exp Hypertens; 2021 Jan; 43(1):7-12. PubMed ID: 32635757
    [No Abstract]   [Full Text] [Related]  

  • 12. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Plasma Renin Activity Caused by Accelerated-malignant Hypertension in a Patient with Aldosterone-producing Adenoma Complicated with Renal Insufficiency.
    Maruhashi T; Amioka M; Kishimoto S; Ikenaga H; Oki K; Ishida M; Kihara Y; Higashi Y
    Intern Med; 2019 Nov; 58(21):3107-3111. PubMed ID: 31292373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What We Know about and What Is New in Primary Aldosteronism.
    Ekman N; Grossman AB; Dworakowska D
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normoaldosteronemic aldosterone-producing adenoma: immunochemical characterization and diagnostic implications.
    Rossi GP; Gioco F; Fassina A; Gomez-Sanchez CE
    J Hypertens; 2015 Dec; 33(12):2546-9. PubMed ID: 26536091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of primary aldosteronism associated with renal artery stenosis and preclinical Cushing's syndrome.
    Tsunoda K; Abe K; Yamada M; Kato T; Yaoita H; Taguma Y; Goto Y; Ioridani N
    Hypertens Res; 2008 Aug; 31(8):1669-75. PubMed ID: 18971543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary aldosteronism in a general population sample. The Czech post-MONICA study.
    Widimský J; Bruthans J; Wohlfahrt P; Krajčoviechová A; Šulc P; Linhart A; Filipovský J; Lánská V; Cífkova R
    Blood Press; 2020 Jun; 29(3):191-198. PubMed ID: 32036692
    [No Abstract]   [Full Text] [Related]  

  • 18. Pitfalls in the diagnosis and treatment of a hypertensive patient with unilateral primary aldosteronism and contralateral pheochromocytoma: a case report.
    Miyamoto S; Yoshida Y; Ozeki Y; Okamoto M; Gotoh K; Masaki T; Nishida H; Fujinami H; Shin T; Daa T; Asayama Y; Shibata H
    BMC Endocr Disord; 2023 Feb; 23(1):44. PubMed ID: 36797699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two case reports on resistant hypertension].
    Beger C; Haller H; Limbourg FP
    Internist (Berl); 2019 May; 60(5):529-532. PubMed ID: 30707244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.
    Gallay BJ; Ahmad S; Xu L; Toivola B; Davidson RC
    Am J Kidney Dis; 2001 Apr; 37(4):699-705. PubMed ID: 11273868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.